MDMA: Empathogen or love potion?

December 15, 2010, Elsevier

15 December 2010, MDMA or 'ecstasy' increases feelings of empathy and social connection. These 'empathogenic' effects suggest that MDMA might be useful to enhance the psychotherapy of people who struggle to feel connected to others, as may occur in association with autism, schizophrenia, or antisocial personality disorder.

However, these effects have been difficult to measure objectively, and there has been limited research in humans. Now, University of Chicago researchers, funded by the National Institute on Drug Abuse, are reporting their new findings in healthy volunteers in the current issue of .

Dr. Gillinder Bedi, author, explained: "We found that MDMA produced friendliness, playfulness, and loving feelings, even when it was administered to people in a laboratory with little social contact. We also found that MDMA reduced volunteers' capacity to recognize of fear in other people, an effect that may be involved in the increased sociability said to be produced by MDMA."

These data suggest that MDMA produces effects that make others seem more attractive and friendly, which may serve as a significant motivator in its use as a recreational drug. Importantly, it also makes others appear less threatening, which could increase users' social risk-taking.

"Within the context of treatment, these effects may promote intimacy among people who have difficulty feeling close to others," observed Dr. John Krystal, Editor of Biological Psychiatry. "However, MDMA distorts one's perception of others rather than producing true empathy. Thus, MDMA may cause problems if it leads people to misinterpret the and perhaps intentions of others."

Certainly, further research in controlled settings is necessary before MDMA could be considered for use as a psychotherapy treatment. But, these findings also underscore the need to understand more about the ways in which different drugs affect social experiences, given that abused drugs are so commonly used in social settings.

Related Stories

Recommended for you

Internet therapy apps reduce depression symptoms, study finds

December 7, 2018
In a sweeping new study, Indiana University psychologists have found that a series of self-guided, internet-based therapy platforms effectively reduce depression.

Gender bias sways how we perceive competence in faces

December 7, 2018
Faces that are seen as competent are also perceived as more masculine, according to research published in Psychological Science, a journal of the Association for Psychological Science.

Targeted cognitive training benefits patients with severe schizophrenia

December 7, 2018
Schizophrenia is among the most difficult mental illnesses to treat, in part because it is characterized by a wide range of dysfunction, from hallucinations and mood disorders to cognitive impairment, especially verbal and ...

Pot withdrawal eased for dependent users

December 6, 2018
A new drug can help people diagnosed with cannabis use disorder reduce withdrawal symptoms and marijuana use, a new Yale-led study published Dec. 6 in the journal Lancet Psychiatry shows.

Link between neonatal vitamin D deficiency and schizophrenia confirmed

December 6, 2018
Newborns with vitamin D deficiency have an increased risk of schizophrenia later in life, a team of Australian and Danish researchers has reported.

Alterations in brain networks explain why some children are resilient to maltreatment

December 6, 2018
People who experience childhood maltreatment frequently have perturbations in their brain architecture, regardless of whether they develop psychiatric symptoms, but a study in Biological Psychiatry found additional alterations ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

JRDarby
5 / 5 (1) Dec 15, 2010
"...there has been limited research in humans. Now, University of Chicago researchers, funded by the National Institute on Drug Abuse, are reporting their new findings in healthy volunteers in the current issue of Biological Psychiatry."

As usual, NIDA is years behind on their research. Why has there been no mention in this article of the MAPS research under way on MDMA in psychotherapy?

http://www.maps.o...ch/mdma/
gwrede
1 / 5 (1) Dec 15, 2010
MDMA or 'ecstasy' increases feelings of empathy and social connection.
We found that MDMA produced friendliness, playfulness, and loving feelings, even when it was administered to people in a laboratory with little social contact.
I don't see how the above results in the following:
However, MDMA distorts one's perception of others rather than producing true empathy.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.